Hjem › Multipel sklerose › Ohio
Multipel sklerose kliniske forsøg i Ohio
14 studier for Multipel sklerose søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- University of Cincinnati Medical Center, Cincinnati
- Riverside Methodist Hospital, Columbus
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 1. okt. 2026 · NCT06782490A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 25. sep. 2026 · NCT07840326Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Cincinnati
- og 4 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06433752Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT07477639RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- The Ohio State University- Site Number : 8400009, Columbus
- The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
RekruttererFase 3
Alder 18 til 60 · Alle køn · Opdateret 15. sep. 2026 · NCT07325292A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Cleveland
- TG Therapeutics Investigational Trial Site, Columbus
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06680037An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, Cleveland
RekruttererFase 1
Alder 18 til 60 · Alle køn · Opdateret 25. aug. 2026 · NCT07224373Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis
- Louis Stokes Cleveland VA Medical Center, Cleveland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT07768761Understanding and Enhancing Human Health and Movement
- Louis Stokes Cleveland VA Medical Center, Cleveland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07738978Care in Multiple Sclerosis (MS)
- Cleveland Clinic, Cleveland
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT07011914Central Vein Sign in Multiple Sclerosis Extension Study
- Cleveland Clinic Foundation, Cleveland
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 20. feb. 2026 · NCT07424027Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
Rekrutterer
Alder 22 til 75 · Alle køn · Opdateret 24. sep. 2025 · NCT05964829Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.